Efficacy and Safety of a Pegasparaginase-Based Chemotherapy Regimen vs an L-asparaginase–Based Chemotherapy Regimen for Newly Diagnosed Advanced Extranodal Natural Killer/T-Cell Lymphoma

医学 养生 内科学 吉西他滨 随机对照试验 化疗 依托泊苷 外科 胃肠病学
作者
Xinhua Wang,Lei Zhang,Xiangli Liu,Xin Li,Ling Li,Xiaorui Fu,Zhenchang Sun,Jingjing Wu,Xudong Zhang,Jiaqin Yan,Yu Chang,Feifei Nan,Zhi‐Yuan Zhou,Xiaolong Wu,Tian Li,Minrui Ma,Zhaoming Li,Hui Yu,Linan Zhu,Yingjun Wang
出处
期刊:JAMA Oncology [American Medical Association]
卷期号:8 (7): 1035-1035 被引量:58
标识
DOI:10.1001/jamaoncol.2022.1968
摘要

Importance: The L-asparaginase-based SMILE (dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide) chemotherapy regimen has shown higher response rates and survival benefit over an anthracycline-containing regimen. However, the safety profile was not satisfied. A well-tolerated regimen with promising efficacy is lacking. Objective: To compare the efficacy and safety of the DDGP (dexamethasone, cisplatin, gemcitabine, and pegaspargase) regimen with the SMILE regimen in newly diagnosed advanced-stage (III/IV) extranodal natural killer/T-cell lymphoma (ENKL). Design, Setting, and Participants: This was an open-label, multicenter, randomized clinical trial that took place across 12 participating hospitals in China from January 2011 to February 2019. Patients were eligible if they were 14 to 70 years old with newly diagnosed ENKL in stages III/IV and had an Eastern Cooperative Oncology Group performance status of 0 to 2. Eligible patients were evenly randomized to either the DDGP or SMILE group. Interventions: Patients in each group were treated with the assigned regimen every 21 days for 6 cycles. Main Outcomes and Measures: The primary end point was progression-free survival (PFS), and secondary end points included overall response rate and overall survival (OS). The adverse events between the DDGP and SMILE groups were compared. Results: Among the 87 randomized patients, 80 received treatment (40 in the DDGP group and 40 in the SMILE group); the median (IQR) age was 43 (12) years, and 51 (64%) were male. The baseline characteristics were similar between the groups. At a median follow-up of 41.5 months, the median PFS was not reached in the DDGP group vs 6.8 months in the SMILE group (HR, 0.42; 95% CI, 0.23-0.77; P = .004), and the median OS was not reached in the DDGP group vs 75.2 months in the SMILE group (HR, 0.41; 95% CI, 0.19-0.89, P = .02). The PFS rate at 3 years and OS rate at 5 years were higher in the DDGP group vs the SMILE group (3-year PFS, 56.6% vs 41.8%; 5-year OS, 74.3% vs 51.7%). The overall response rate was higher in the DDGP group than in the SMILE group (90.0% vs 60.0%; P = .002). Grade 3 and 4 hematologic toxic effects were more frequently reported in the SMILE group vs the DDGP group (leukopenia, 85.0% vs 62.5%; neutropenia, 85.0% vs 65.0%). Conclusions and Relevance: In this randomized clinical trial, the DDGP regimen showed promising preliminary results for patients with newly diagnosed local advanced ENKL. A confirmation trial based on larger population is warranted. Trial Registration: ClinicalTrials.gov Identifier: NCT01501149.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
吐泡泡完成签到,获得积分10
刚刚
Clover完成签到,获得积分20
刚刚
科研通AI6.3的应助被鼻毛好胜采纳,获得10
1秒前
风趣健柏发布了新的文献求助10
1秒前
拼搏幻竹完成签到 ,获得积分10
2秒前
Uuonnggi发布了新的文献求助10
2秒前
zhangyq发布了新的文献求助10
2秒前
3秒前
追寻思雁发布了新的文献求助10
3秒前
3秒前
jr发布了新的文献求助10
3秒前
3秒前
小迷鹿发布了新的文献求助10
4秒前
6666发布了新的文献求助50
4秒前
四方发布了新的文献求助10
4秒前
4秒前
Qingsic发布了新的文献求助10
4秒前
FashionBoy的应助被微血管采纳,获得10
4秒前
4秒前
5秒前
SS发布了新的文献求助10
5秒前
amo完成签到,获得积分10
6秒前
ding发布了新的文献求助10
6秒前
万能图书馆的应助被大尾巴鱼采纳,获得10
6秒前
深情安青的应助被灵巧的嚣采纳,获得100
6秒前
MST发布了新的文献求助10
7秒前
lingling发布了新的文献求助10
8秒前
8秒前
orange发布了新的文献求助10
10秒前
10秒前
充电宝的应助被ding采纳,获得10
10秒前
Maestro_S的应助被Tang采纳,获得10
10秒前
Lyr完成签到,获得积分10
10秒前
欣慰的千易完成签到,获得积分20
11秒前
秋风的应助被美丽采纳,获得10
11秒前
17764715645发布了新的文献求助10
11秒前
12秒前
12秒前
Pkaming完成签到,获得积分10
12秒前
新新新新新发顶刊完成签到 ,获得积分10
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8187652
求助须知:如何正确求助?哪些是违规求助? 9575758
关于积分的说明 21842805
捐赠科研通 7785538
什么是DOI,文献DOI怎么找? 3435073
关于科研通互助平台的介绍 2559480
邀请新用户注册赠送积分活动 2481963